CollPlant Biotechnologies Ltd. (CLGN)
3.51
-0.46
(-11.59%)
USD |
NASDAQ |
Oct 09, 16:00
3.61
+0.10
(+2.85%)
After-Hours: 20:00
CollPlant Biotechnologies Total Liabilities (Quarterly) : 4.252M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.252M |
| March 31, 2026 | 4.297M |
| December 31, 2025 | 4.704M |
| September 30, 2025 | 4.784M |
| June 30, 2025 | 4.932M |
| March 31, 2025 | 4.811M |
| December 31, 2024 | 5.245M |
| September 30, 2024 | 5.524M |
| June 30, 2024 | 5.837M |
| March 31, 2024 | 5.846M |
| December 31, 2023 | 5.786M |
| September 30, 2023 | 5.16M |
| June 30, 2023 | 5.53M |
| March 31, 2023 | 5.869M |
| December 31, 2022 | 5.487M |
| September 30, 2022 | 4.752M |
| June 30, 2022 | 4.908M |
| March 31, 2022 | 5.527M |
| December 31, 2021 | 6.103M |
| September 30, 2021 | 5.154M |
| June 30, 2021 | 5.582M |
| March 31, 2021 | 5.985M |
| December 31, 2020 | 6.364M |
| September 30, 2020 | 5.901M |
| June 30, 2020 | 5.171M |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | 14.09M |
| June 30, 2019 | 7.523M |
| March 31, 2019 | 8.216M |
| December 31, 2018 | 4.006M |
| September 30, 2018 | 2.173M |
| June 30, 2018 | 2.409M |
| March 31, 2018 | 1.701M |
| December 31, 2017 | 5.115M |
| September 30, 2017 | 3.230M |
| June 30, 2017 | 1.185M |
| March 31, 2017 | 1.369M |
| December 31, 2016 | 1.843M |
| September 30, 2016 | 1.322M |
| June 30, 2016 | 1.096M |
| March 31, 2016 | 0.9541M |
| December 31, 2015 | 0.9638M |
| September 30, 2015 | 0.8454M |
| June 30, 2015 | 0.6768M |
| March 31, 2015 | 0.7222M |
| December 31, 2014 | 0.6802M |
| September 30, 2014 | 0.6061M |
| June 30, 2014 | 0.6061M |
| March 31, 2014 | 0.6656M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 46.19M |
| Perspective Therapeutics, Inc. | 68.16M |
| MiMedx Group, Inc. | 65.00M |
| Regentis Biomaterials Ltd. | -- |
| Xylo Technologies Ltd. | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.197M |
| Shareholders Equity (Quarterly) | 2.945M |
| Debt to Equity Ratio | 0.9032 |
| Current Ratio | 1.567 |
| Net Debt Paydown Yield | 0.73% |